{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T04:54:33Z","timestamp":1758862473413,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ypmed.2017.01.022","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T05:16:53Z","timestamp":1486617413000},"page":"13-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Scorecard for spina bifida research, prevention, and policy \u2013 A development process"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2803-8030","authenticated-orcid":false,"given":"Vijaya","family":"Kancherla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salimah R.","family":"Walani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliki P.","family":"Weakland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieven","family":"Bauwens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Godfrey P.","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin C.","family":"Warf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ypmed.2017.01.022_bb0005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/bdra.23529","article-title":"A 2015 global update on folic acid-preventable spina bifida and anencephaly","volume":"106","author":"Arth","year":"2016","journal-title":"Birth. Defects. Res. A. Clin. Mol. Teratol."},{"issue":"1","key":"10.1016\/j.ypmed.2017.01.022_bb0010","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.2105\/AJPH.2015.302902","article-title":"Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis","volume":"106","author":"Atta","year":"2016","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.ypmed.2017.01.022_bb0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cch.12367","article-title":"Health-related quality of life in children with myelomeningocele: a systematic review of the literature","volume":"42","author":"Bakaniene","year":"2016","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.ypmed.2017.01.022_bb0020","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199911113412001","article-title":"Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention","volume":"341","author":"Berry","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"9890","key":"10.1016\/j.ypmed.2017.01.022_bb0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(13)60996-4","article-title":"Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?","volume":"382","author":"Bhutta","year":"2013","journal-title":"Lancet"},{"issue":"9940","key":"10.1016\/j.ypmed.2017.01.022_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(14)60792-3","article-title":"Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?","volume":"384","author":"Bhutta","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2017.01.022_bb0035","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199911113412006","article-title":"Neural-tube defects","volume":"341","author":"Botto","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ypmed.2017.01.022_bb0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/bdra.20307","article-title":"Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment","volume":"76","author":"Botto","year":"2006","journal-title":"Birth. Defects. Res. A. Clin. Mol. Teratol."},{"issue":"5","key":"10.1016\/j.ypmed.2017.01.022_bb0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1017\/S1368980012003576","article-title":"Impact of folic acid fortification of flour on neural tube defects: a systematic review","volume":"16","author":"Castillo-Lancellotti","year":"2013","journal-title":"Public Health Nutr."},{"year":"2006","series-title":"Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children","author":"Christianson","key":"10.1016\/j.ypmed.2017.01.022_bb0050"},{"issue":"15","key":"10.1016\/j.ypmed.2017.01.022_bb0055","first-page":"421","article-title":"Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines","volume":"64","author":"Cordero","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2017.01.022_bb0060","first-page":"g4554","article-title":"Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model","volume":"349","author":"Crider","year":"2014","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.ypmed.2017.01.022_bb0065","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation","volume":"327","author":"Czeizel","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ypmed.2017.01.022_bb0070","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jamapediatrics.2016.0388","article-title":"Prevention of congenital disorders and care of affected children: a consensus statement","volume":"170","author":"Darmstadt","year":"2016","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.ypmed.2017.01.022_bb0075","unstructured":"Flores, A.L., Vellozzi, C., Valencia, D., Sniezek., J. 2014. Global burden of neural tube defects, risk factors, and prevention. Indian. J. Community. Health. 26(Suppl 1), 3\u20135."},{"issue":"9963","key":"10.1016\/j.ypmed.2017.01.022_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study","volume":"385","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ypmed.2017.01.022_bb0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1017\/S1368980015000555","article-title":"Folate and folic acid in the periconceptional period: recommendations from official health organizations in thirty-six countries worldwide and WHO","volume":"19","author":"Gomes","year":"2016","journal-title":"Public Health Nutr."},{"issue":"5 Suppl 1","key":"10.1016\/j.ypmed.2017.01.022_bb0090","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.amepre.2015.10.012","article-title":"Retrospective assessment of cost savings from prevention. Folic acid fortification and spina bifida in the U.S.","volume":"50","author":"Grosse","year":"2016","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ypmed.2017.01.022_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(14)60496-7","article-title":"Progress, priorities, and potential beyond survival","volume":"384","author":"Lawn","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ypmed.2017.01.022_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/DBP.0b013e31820b49fc","article-title":"Social participation in a nationally representative sample of older youth and young adults with autism","volume":"32","author":"Liptak","year":"2011","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.ypmed.2017.01.022_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","article-title":"Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group","volume":"338","author":"MRC Vitamin Study Research Group","year":"1991","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ypmed.2017.01.022_bb0110","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJMp1510082","article-title":"Shifting to sustainable developmental goals: implications for global health","volume":"373","author":"Murray","year":"2015","journal-title":"N. Engl. J. Med."},{"author":"Sustainable Developmental Goals","key":"10.1016\/j.ypmed.2017.01.022_bb0115"},{"issue":"10","key":"10.1016\/j.ypmed.2017.01.022_bb0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/bdra.20498","article-title":"Survival and disability in a cohort of neural tube defect births in Dublin, Ireland","volume":"82","author":"Sutton","year":"2008","journal-title":"Birth. Defects. Res. A. Clin. Mol. Teratol."},{"author":"United Nations","key":"10.1016\/j.ypmed.2017.01.022_bb0125"},{"year":"2015","series-title":"Guideline: Optimal Serum and Red Blood Cell Folate Concentrations in Women of Reproductive Age for Prevention of Neural Tube Defects","author":"World Health Organization","key":"10.1016\/j.ypmed.2017.01.022_bb0130"},{"author":"World Health Organization","key":"10.1016\/j.ypmed.2017.01.022_bb0135"},{"issue":"4","key":"10.1016\/j.ypmed.2017.01.022_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151586","article-title":"Describing the prevalence of neural tube defects worldwide: a systematic literature review","volume":"11","author":"Zaganjor","year":"2016","journal-title":"PLoS One"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743517300464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743517300464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T08:27:39Z","timestamp":1536049659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743517300464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":28,"alternative-id":["S0091743517300464"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.01.022","relation":{},"ISSN":["0091-7435"],"issn-type":[{"type":"print","value":"0091-7435"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scorecard for spina bifida research, prevention, and policy \u2013 A development process","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2017.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}